Circulating tumor cells (CTCs)—an intermediate form of cancer cell between a primary and metastatic tumor cell—carry a treasure trove of information that is critical to treating cancer. Numerous engineering advancements ...
Jan 22, 2019
0
91
NIBIB-funded researchers have created a novel, low-cost biosensor to detect HER-2, a breast cancer biomarker in the blood, allowing for a far less invasive diagnostic test than the current practice, a needle biopsy. Scientists ...
Dec 10, 2018
0
3
For couples hoping for a baby via in vitro fertilization, chances have improved. A process that once took hours now takes minutes: Cornell University scientists have created a microfluidic device that quickly corrals strong ...
Sep 10, 2018
0
21
Researchers are developing early detection technology for Type 1 diabetes that can accurately predict if a child is at risk of the chronic disease.
Jul 10, 2018
0
0
Combinations of cancer drugs can be quickly and cheaply tested on tumour cells using a novel device developed by EMBL scientists. The research, reported in Nature Communications on June 22, marks the latest advancement in ...
Jun 22, 2018
0
4
For years, bioengineer Yaling Liu has been in pursuit of the deadly tumor cell. Liu has been perfecting a microfluidic device the size of two quarters that has the ability to catch and release circulating tumor cells (CTCs)—cancer ...
Apr 18, 2018
0
3
A microfluidic device developed by Massachusetts General Hospital (MGH) investigators may help solve a significant and persistent challenge in medicine—diagnosing the life-threatening complication of sepsis. In their paper ...
Mar 19, 2018
0
38
Researchers at the University of Huddersfield have helped develop a lab device that could speed up the adoption of new anti-cancer treatments.
Dec 15, 2016
0
1
Researchers at Florida State University's nationally renowned biomathematics program are using a mix of math and technology in an ambitious search for a cure to Type 2 diabetes.
Nov 29, 2016
0
55
Researchers in the Cockrell School of Engineering at The University of Texas at Austin have developed the first large-scale in vivo drug discovery platform using a whole animal model that could speed up scientific research ...
Oct 11, 2016
0
0
